Krensavage Asset Management as of Dec. 31, 2016
Portfolio Holdings for Krensavage Asset Management
Krensavage Asset Management holds 16 positions in its portfolio as reported in the December 2016 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
United Therapeutics Corporation (UTHR) | 13.9 | $39M | 271k | 143.43 | |
Enanta Pharmaceuticals (ENTA) | 12.7 | $35M | 1.1M | 33.50 | |
Gilead Sciences (GILD) | 10.8 | $30M | 420k | 71.61 | |
Sucampo Pharmaceuticals | 9.1 | $25M | 1.9M | 13.55 | |
Orthofix International Nv Com Stk | 8.4 | $23M | 646k | 36.18 | |
Halyard Health | 7.5 | $21M | 565k | 36.98 | |
Amgen (AMGN) | 6.7 | $19M | 127k | 146.21 | |
Indivior | 6.1 | $17M | 4.7M | 3.65 | |
Merck & Co (MRK) | 5.3 | $15M | 253k | 58.87 | |
CONMED Corporation (CNMD) | 5.2 | $15M | 329k | 44.17 | |
Invacare Corporation | 5.2 | $14M | 1.1M | 13.05 | |
RTI Biologics | 4.9 | $14M | 4.2M | 3.25 | |
Derma Sciences | 1.7 | $4.6M | 891k | 5.20 | |
Aviragen Therapeutics | 1.2 | $3.4M | 2.7M | 1.23 | |
Digirad Corporation | 0.9 | $2.4M | 486k | 5.00 | |
Juniper Pharmaceuticals Incorporated | 0.6 | $1.6M | 291k | 5.60 |